Merit Medical Systems, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 2 | $0.71 | $0.71 | $0.71 |
Q2 2024 | 2 | $0.86 | $0.89 | $0.87 |
Q3 2024 | 3 | $0.80 | $0.80 | $0.80 |
Q4 2024 | 8 | $0.80 | $0.83 | $0.82 |
Q1 2025 | 6 | $0.80 | $0.89 | $0.83 |
Q2 2025 | 5 | $0.96 | $0.99 | $0.98 |
Q3 2025 | 5 | $0.92 | $0.95 | $0.94 |
Q4 2025 | 5 | $0.94 | $0.97 | $0.96 |
Q1 2026 | 2 | $0.90 | $0.93 | $0.91 |
Q2 2026 | 2 | $1.04 | $1.07 | $1.05 |
Q3 2026 | 2 | $1.02 | $1.05 | $1.03 |
Q4 2026 | 2 | $1.10 | $1.13 | $1.12 |
Merit Medical Systems, Inc. Earnings Date And Information
Merit Medical Systems, Inc. last posted its earnings results on Wednesday, October 30th, 2024. The company reported $0.86 earnings per share for the quarter, topping analysts' consensus estimates of $0.8 by $0.06. The company had revenue of 339.85 M for the quarter and had revenue of 1.26 B for the year. Merit Medical Systems, Inc. has generated $2 earnings per share over the last year ($1.62 diluted earnings per share) and currently has a price-to-earnings ratio of 51.1. Merit Medical Systems, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Merit Medical Systems, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
10/30/2024 | Q3 2024 | $0.80 | $0.49 | -0.31 | $334.60 M | $339.85 M |
08/01/2024 | Q2 2024 | $0.88 | $0.61 | -0.27 | $334.56 M | $337.58 M |
04/30/2024 | Q1 2024 | $0.71 | $0.49 | -0.22 | $323.51 M | |
02/28/2024 | Q4 2023 | $0.77 | $0.48 | -0.29 | $323.29 M | |
10/26/2023 | Q3 2023 | $0.65 | $0.45 | -0.2 | $306.19 M | $315.23 M |
07/28/2023 | Q2 2023 | $0.35 | $310.10 M | $320.06 M | ||
04/28/2023 | Q1 2023 | $0.36 | $297.57 M | |||
02/24/2023 | Q4 2022 | $0.59 | $293.42 M | |||
10/28/2022 | Q3 2022 | $0.27 | $272.52 M | $287.18 M | ||
08/05/2022 | Q2 2022 | $0.27 | $280.55 M | $294.98 M | ||
05/06/2022 | Q1 2022 | $0.19 | $275.42 M | |||
03/01/2022 | Q4 2021 | $0.36 | $278.49 M | |||
11/05/2021 | Q3 2021 | $0.21 | $260.61 M | $267.02 M | ||
08/06/2021 | Q2 2021 | $0.09 | $250.60 M | $280.33 M | ||
05/07/2021 | Q1 2021 | $0.20 | $248.91 M | |||
03/01/2021 | Q4 2020 | $0.28 | $258.00 M | |||
11/05/2020 | Q3 2020 | -$0.05 | $217.63 M | $243.98 M | ||
08/06/2020 | Q2 2020 | -$0.34 | $192.67 M | $218.37 M | ||
05/11/2020 | Q1 2020 | -$0.06 | $243.53 M | |||
03/02/2020 | Q4 2019 | -$0.08 | $257.92 M |
Merit Medical Systems, Inc. Earnings: Frequently Asked Questions
-
When is Merit Medical Systems, Inc.'s earnings date?
Merit Medical Systems, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
-
Did Merit Medical Systems, Inc. beat their earnings estimates last quarter?
In the previous quarter, Merit Medical Systems, Inc. (:MMSI) reported $0.86 earnings per share (EPS) to beat the analysts' consensus estimate of $0.8 by $0.06.
-
How can I listen to Merit Medical Systems, Inc.'s earnings conference call?
The conference call for Merit Medical Systems, Inc.'s latest earnings report can be listened to online.
-
How can I read Merit Medical Systems, Inc.'s conference call transcript?
The conference call transcript for Merit Medical Systems, Inc.'s latest earnings report can be read online.
-
How much revenue does Merit Medical Systems, Inc. generate each year?
Merit Medical Systems, Inc. (:MMSI) has a recorded annual revenue of $1.26 B.
-
How much profit does Merit Medical Systems, Inc. generate each year?
Merit Medical Systems, Inc. (:MMSI) has a recorded net income of $1.26 B. Merit Medical Systems, Inc. has generated $1.64 earnings per share over the last four quarters.
-
What is Merit Medical Systems, Inc.'s price-to-earnings ratio?
Merit Medical Systems, Inc. (:MMSI) has a price-to-earnings ratio of 51.1 and price/earnings-to-growth ratio is 25.93.